Table of Contents Author Guidelines Submit a Manuscript
The Scientific World Journal
Volume 2012 (2012), Article ID 718279, 6 pages
http://dx.doi.org/10.1100/2012/718279
Research Article

Acute Effects of Vardenafil on Pulmonary Artery Responsiveness in Pulmonary Hypertension

1Department of Pharmacology, Akdeniz University School of Medicine, 07070 Antalya, Turkey
2Department of Pathology, Akdeniz University School of Medicine, 07070 Antalya, Turkey

Received 11 October 2011; Accepted 28 December 2011

Academic Editors: K. G. Birukov, Y. Takiguchi, and F. Varoli

Copyright © 2012 Edibe Karasu-Minareci et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Citations to this Article [8 citations]

The following is the list of published articles that have cited the current article.

  • Andrew James Wardle, and Robert M. R. Tulloh, “Evolving Management of Pediatric Pulmonary Arterial Hypertension: Impact of Phosphodiesterase Inhibitors,” Pediatric Cardiology, vol. 34, no. 2, pp. 213–219, 2012. View at Publisher · View at Google Scholar
  • Edibe Karasu-Minareci, “Tadalafil in pulmonary hypertension: May be more than seen?,” Human & Experimental Toxicology, vol. 31, no. 11, pp. 1186–1187, 2012. View at Publisher · View at Google Scholar
  • Dan-Chen Wu, Hong-Da Zhang, and Zhi-Cheng Jing, “Pediatric Pulmonary Arterial Hypertension,” Current Hypertension Reports, 2013. View at Publisher · View at Google Scholar
  • Edibe Minareci, and Gulay Sadan, “An evaluation of vardenafil as a calcium channel blocker in pulmonary artery in rats,” Indian Journal of Pharmacology, vol. 46, no. 2, pp. 185–190, 2014. View at Publisher · View at Google Scholar
  • Anna Sandqvist, Dan Henrohn, Hanna Egeröd, Mikael Hedeland, Lisa Wernroth, Ulf Bondesson, Jörn Schneede, and Gerhard Wikström, “Acute vasodilator response to vardenafil and clinical outcome in patients with pulmonary hypertension,” European Journal of Clinical Pharmacology, 2015. View at Publisher · View at Google Scholar
  • Edibe Minareci, Cahit Nacitarhan, Zeliha Bayram, and Sadi Ozdem, “Inhibitory effect of sildenafil on pyloric sphincter from streptozotocin-diabetic rats: role of no-cGMP transduction pathway,” International Journal Of Diabetes In Developing Countries, vol. 35, no. 4, pp. 418–424, 2015. View at Publisher · View at Google Scholar
  • Taymour Mostafa, “Non-Sexual Implications of Phosphodiesterase Type 5 Inhibitors,” Sexual Medicine Reviews, 2016. View at Publisher · View at Google Scholar
  • Mariann Bombicz, Daniel Priksz, Balazs Varga, Andrea Kurucz, Attila Kertész, Akos Takacs, Aniko Posa, Rita Kiss, Zoltan Szilvassy, and Bela Juhasz, “A Novel Therapeutic Approach in the Treatment of Pulmonary Arterial Hypertension: Allium ursinum Liophylisate Alleviates Symptoms Comparably to Sildenafil,” International Journal of Molecular Sciences, vol. 18, no. 7, pp. 1436, 2017. View at Publisher · View at Google Scholar